Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05900687 · ClinicalTrials.gov registry record · NA
Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT05900687: Clinical Trial NA study, sponsored by Stanford University.
NCT05900687 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05900687, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
More than 40% of patients with gastroesophageal reflux disease (GERD) experience uncontrolled, chronic symptoms. This proposal aims to improve symptom control for patients with GERD, by developing a mobile health (mHealth) Question Prompt List (QPL) intervention that helps patient ask questions with his/her physician about GERD. The first aim is to gather feedback about daily challenges of living with GERD. The second aim is to gather feedback on the prototype app. The third (primary) aim of this project is to develop the mHealth application and measure differences in patient activation when used compared to standard of care.
Primary Outcome
Patient Activation Measure is a measure of how much activation (knowledge and confidence) participants have in managing their health.
Interventions
- BEHAVIORAL Use of mHealth Question Prompt List app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What is known before NCT05900687 opens enrollment
NCT05900687 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Use of mHealth Question Prompt List app is the first listed.
NCT05900687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05900687 about?
NCT05900687 is a clinical study titled "Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease". More than 40% of patients with gastroesophageal reflux disease (GERD) experience uncontrolled, chronic symptoms. This proposal aims to improve symptom control for patients with GERD, by developing a mobile health (mHealth) Question Prompt List (QPL) intervention that helps patient ask questions with...
What is the current status of trial NCT05900687?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-07-01. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT05900687?
The interventions under investigation include: Use of mHealth Question Prompt List app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05900687?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05900687's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI